Asymptomatic significant patent foramen ovale: Giving patent foramen ovale management back to the cardiologist

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 4, 2008, Pages 573-577

  Rigatelli, Gianluca ^a,b   Cardaioli, Paolo ^a   Chinaglia, Mauro ^a  

^a ROVIGO GENERAL HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Closure; Device; Echocardiography; Patent foramen ovale; Stroke

Indexed keywords

BLOOD CLOTTING DISORDER; CARDIOLOGIST; CARDIOVASCULAR RISK; HEART ANEURYSM; HUMAN; MEDICAL PROFESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; REVIEW; STROKE; CARDIOLOGY; CLINICAL COMPETENCE; EVIDENCE BASED MEDICINE; HEART SURGERY; PARADOXICAL EMBOLISM; PATIENT SELECTION; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR;

CARDIAC SURGICAL PROCEDURES; CARDIOLOGY; CLINICAL COMPETENCE; EMBOLISM, PARADOXICAL; EVIDENCE-BASED MEDICINE; FORAMEN OVALE, PATENT; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 41649119835     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21390     Document Type: Review

References (33)

1. Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, Kasner SE; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;62:1042-1050.
2. SPREAD - Stroke Prevention and Educational Awareness Diffusion: Stroke Italian Guidelines, IV ed.; 2005. Available at www.spread.it.
3. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007;49:797-802.
4. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, Whisnant JP, Wiebers DO, Covalt JL, Petterson TM, Christiansen TJ, Agmon Y. Patent foramen ovale: Innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006;47:440-445.
5. Casaubon L, McLaughlin P, Webb G, Yeo E, Merker D, Jaigobin C. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neurol Sci 2007;34:74-80.
6. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Atrial anatomy in non-cardioembolic stroke patients: Effect of medical therapy. J Am Coll Cardiol 2003;42:1066-1072.
7. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-1088.
8. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J; Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
9. Sastry S, Riding G, Morris J, et al. Young Adult Myocardial Infarction and Ischemic Stroke The Role of Paradoxical Embolism and Thrombophilia (The YAMIS Study). J Am Coll Cardiol 2006;48:686-691.
10. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: Data from 420 patients. Neurology 2006;66:765-767.
11. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999;52:1622-1625.
12. Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really "Shut the Door?" A prospective study with transcranial doppler. Stroke 2004;35:2140-2144.
13. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
14. Bonati LH, Kessel-Schaefer A, Linka AZ, Buser P, Wetzel SG, Radue EW, Lyrer PA, Engelter ST. Diffusion-weighted imaging in stroke attributable to patent foramen ovale: Significance of concomitant atrial septum aneurysm. Stroke 2006;37:2030-2034.
15. Santamarina E, Gonzalez-Alujas MT, Munoz V, Rovira A, Rubiera M, Ribo M, Alvarez-Sabin J, Molina CA. Stroke patients with cardiac atrial septal abnormalities: Differential infarct patterns on DWI. J Neuroimaging 2006;16:334-340.
16. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Denning K, Engberding R. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785-2792.
17. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, Akkawi NM, Albertini A, Assanelli D, Vignolo LA, Padovani A. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003;34:28-33.
18. Dodge SM, Hassell K, Anderson CA, Keller J, Groves B, Carroll JD. Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure. Catheter Cardiovasc Interv 2004;61:123-127.
19. Intiso D, Di Rienzo F, Rinaldi G, Zarrelli MM, Giannatempo GM, Crociani P, Di Viesti P, Simone P. Brain MRI white matter lesions in migraine patients: Is there a relationship with anti-phospholipid antibodies and coagulation parameters? Eur J Neurol 2006;13:1364-1369.
20. Arquizan C, Touze E, Moulin T, Woimant F, Ducrocq X, Mas JL. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Blood pressure, smoking and oral contraceptive control after cryptogenic stroke in young adults in the PFO-ASA Study. Cerebrovasc Dis 2005;20:41-45.
21. Ferrarini G, Malferrari G, Zucco R, Gaddi O, Norina M, Pini LA. High prevalence of patent foramen ovale in migraine with aura. J Headache Pain 2005;6:71-76.
22. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
23. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-291.
24. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758.
25. Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, Khandheria BK. Patent foramen ovale in cryptogenic stroke: Current understanding and management options. Arch Intern Med 2004;164:950-956.
26. Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Liebeskind DS. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007;99:1316-1320.
27. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
28. Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 2006;68:741-746.
29. Onorato E, Melzi G, Casilli F, Pedon L, Rigatelli G, Carrozza A. Patent foramen ovale with paradoxical embolism: Mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003;16:43-50.
30. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003;139:753-760.
31. Rigatelli G, Cardaioli P. Patent foramen ovale management: Who should do what? Eur J Neurol 2007;14:341-342.
32. Rigatelli G. Patent foramen ovale: The evident paradox between the apparently simple treatment and the really complex pathophysiology. J Cardiovasc Med (Hagerstown) 2007;8:300-304.
33. Rigatelli G, Braggion G, Chinaglia M, Cardaioli P, Roncon L, Giordan M, Cuppini S, Aggio S, Bortolazzi A, Zonzin P. Setting up a multidisciplinary program for management of patent foramen ovale-mediated syndromes. J Interv Cardiol 2006;19:264-268.